The possibility that Apelin administration or methods to modulate the APJ receptor could be considered in the context of congenital heart defects and prophylactic cardioprotection for surgical repair involving cardiopulmonary bypass may one day prove to be beneficial although much research is still required. Here, APLNR is linked to congenital heart disease.